New Ventiphylline PD

Salbutamol, also known as albuterol in the United States, is a short-acting, selective β₂-adrenergic receptor agonist used as a bronchodilator to relieve and prevent bronchospasm in conditions such as asthma, chronic obstructive pulmonary disease (COPD), and exercise-induced bronchoconstriction.[1] As a prescription-only medication, its use is indicated exclusively for diagnosed conditions involving reversible bronchospasm; it is not safe or appropriate for shortness of breath from undiagnosed or non-respiratory causes (e.g., cardiac disorders, anxiety, anemia), as such use may fail to address the underlying issue, mask serious conditions, delay proper medical care, or cause adverse effects such as tachycardia, tremors, or paradoxical bronchospasm. Individuals experiencing unexplained shortness of breath should seek immediate medical evaluation.[2][3] It is typically administered via inhalation for rapid onset of action, though oral and intravenous forms exist for specific indications.[3] The drug's selectivity for β₂ receptors over β₁ minimizes cardiac side effects compared to earlier non-selective agents.[4]